Group 1 - The core viewpoint of the articles highlights the performance and valuation of Xishan Technology in the medical device industry, noting its current stock price and market capitalization [1][2] - As of August 12, Xishan Technology's stock closed at 74.63 yuan, with a PE ratio of 40.30, marking a new low in 209 days, and a total market value of 3.396 billion yuan [1] - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, positioning Xishan Technology at the 75th rank within the industry [1][2] Group 2 - Xishan Technology's main business involves the research, manufacturing, sales, and service of surgical medical devices, including surgical power tools, endoscopic systems, and energy surgical equipment [1] - The latest financial results for Q1 2025 show that the company achieved a revenue of 65.8771 million yuan, a year-on-year decrease of 11.20%, and a net profit of 11.4768 million yuan, down 55.66% year-on-year, with a gross margin of 67.64% [1]
西山科技收盘上涨1.75%，滚动市盈率40.30倍，总市值33.96亿元